市場調查報告書

失眠症:全球市場的未來展望

Insomnia - Global Market Outlook (2017-2023)

出版商 Stratistics Market Research Consulting 商品編碼 573082
出版日期 內容資訊 英文 198 Pages
商品交期: 2-3個工作天內
價格
Back to Top
失眠症:全球市場的未來展望 Insomnia - Global Market Outlook (2017-2023)
出版日期: 2017年10月01日內容資訊: 英文 198 Pages
簡介

本報告提供全球失眠症的市場相關分析,技術、相關疾病概要,及市場基本結構及促進、阻礙因素,產業的向心力、競爭環境,各治療法、症狀的各持續期間、各症狀、各劑型、各地區的市場趨勢預測 (過去3年、今後7年份),重要的資本交易的動向,主要企業簡介等調查。

第1章 摘要整理

第2章 序論

第3章 市場趨勢分析

  • 簡介
  • 市場的推動要素
  • 市場的阻礙要素
  • 市場機會
  • 威脅
  • 新興國家市場
  • 未來市場方案

第4章 波特的五力分析

  • 供應商談判力
  • 買主談判力
  • 替代產品的威脅
  • 新加入企業的威脅
  • 企業間競爭

第5章 全球失眠症市場:治療方法的各類型

  • 簡介
  • 藥物治療
    • 市售 (OTC) 安眠藥
      • 褪黑激素
      • 抗組織胺藥物
      • 纈草根
      • 其他藥用植物、補充品
    • 處方安眠藥
      • 苯二氮平類
      • Orexin拮抗劑
      • 非苯二氮平類 (Eszopiclone、Zolpidem、Zaleplon)
      • 其他 (三環系抗憂鬱劑,抗精神病藥,氯醛衍生物)
  • 非藥物治療
    • 醫療設備
    • 認識、行動療法
    • 催眠療法
    • 反論的思考
    • 睡眠衛生教育
    • 刺激控制
    • 其他 (針灸,音樂療法,芳香療法,瑜伽等)

第6章 全球失眠症市場:症狀的各持續期間

  • 簡介
  • 慢性失眠症
  • 一時性失眠症
  • 急性失眠症

第7章 全球失眠症市場:各症狀

  • 簡介
  • 入睡障礙,途中覺醒
  • 睡眠的品質惡劣
  • 其他症狀

第8章 全球失眠症市場:劑型的各類型

  • 簡介
  • 膠囊
  • 藥丸
    • 舌下含片
    • 薄膜包衣片
  • 口內保濕劑

第9章 全球失眠症市場:各地區

  • 簡介
  • 北美 (美國,加拿大,墨西哥)
  • 歐洲 (德國,英國,法國,義大利,西班牙等)
  • 亞太地區 (日本,中國,印度,澳洲,紐西蘭,韓國等)
  • 南美 (阿根廷,巴西,智利等)
  • 中東、非洲 (沙烏地阿拉伯,UAE,卡達,南非等)

第10章 近幾年的主要趨勢

  • 協定,事業協定、合作,合資企業
  • 企業合併、收購 (M&A)
  • 新產品的銷售
  • 事業擴張
  • 其他主要策略

第11章 企業簡介

  • Astellas Pharma Inc.
  • Biocodex S A
  • Consumer Healthcare Inc.
  • 大日本住友製藥
  • ECR Pharmaceuticals
  • Eisai
  • Flynn Pharma
  • Johnson & Johnson
  • Meda Consumer Healthcare Inc.
  • Merck & Co. Inc.
  • Neurim
  • Pernix Therapeutics
  • Pfizer Inc
  • Purdue Pharma L.P.
  • Sanofi Pasteur
  • SkyePharma
  • 武田藥品工業

圖表一覽

目錄

According to Stratistics MRC, the Global Insomnia market is expected to grow from $XX million in 2016 to reach $XX million by 2023 with a CAGR of XX%. Working in rational shifts & stressful work conditions, recent technological advancements and increasing demand for OTC sleep aids are some of the factors favoring the market growth. In addition, presence of large undiagnosed insomnia population pool and untapped markets in developing economies are the key opportunities for the market growth. On the contrary, side effects of benzodiazepine and non-benzodiazepine drugs, expiration of patients and increase in non pharmacological therapies are hindering the market growth.

Insomnia is a sleep disorder where in the person faces difficultly to sleep or remain asleep. The indications include depression, irritability, low stamina and daytime sleepiness. It is a highly predominant disorder that affects millions of people, globally. Insomnia-related conditions are caused due to disruption in circadian rhythm, chronic pain, hyperthyroidism, menopause, psychological stress, and other medical conditions. Furthermore, usage of drugs, such as alcohol, nicotine and caffeine will lead to insomnia.

In 2016, North America accounted for the highest market share in the insomnia market and is expected to maintain its dominance throughout the forecast period. In the U.S., the OTC treatment market is expected to hold a greater CAGR to address its growth in the insomnia pharmacological treatment. It is predicted to earn backing from the increasing utilization of melatonin valerian and roots, outstanding to their crucial advantages such as reduced stress levels and low side effects. Asia Pacific also appeared as a proper opportunity to capitalize on with the lifting disposable income and upsurge in the occurrence of chronic diseases.

Some of the key players in global insomnia market include Astellas, Biocodex S A, Consumer Healthcare Inc., Dainippon Sumitomo, ECR Pharmaceuticals, Eisai Co., Flynn Pharma, Johnson & Johnson, Meda Consumer Healthcare Inc., Merck & Co. Inc., Neurim, Pernix, Therapeutics, Pfizer Inc, Purdue Pharma L.P., Sanofi Pasteur, SkyePharma and Takeda Pharmaceutical Company.

Therapy Type Covered:

  • Pharmacological Therapy
  • Non-pharmacological Therapy

Disorder Durations Covered:

  • Chronic Insomnia
  • Transient Insomnia
  • Acute Insomnia

Disorder Conditions Covered:

  • Sleep onset and/or Maintenance
  • Poor Quality of Sleep
  • Other Disorder Condition

Formulation Types Covered:

  • Capsules
  • Tablets
  • Oral mists

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Emerging Markets
  • 3.7 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Insomnia Market, By Therapy Type

  • 5.1 Introduction
  • 5.2 Pharmacological Therapy
    • 5.2.1 Over-the-Counter sleep aids
      • 5.2.1.1 Melatonin
      • 5.2.1.2 Antihistamines
      • 5.2.1.3 Valerian roots
      • 5.2.1.4 Other Herbal and dietary supplements
    • 5.2.2 Prescription sleep aids
      • 5.2.2.1 Benzodiazepines
      • 5.2.2.2 Orexin Antagonists
      • 5.2.2.3 Melatonin Receptor Agonists
      • 5.2.2.4 Non-benzodiazepines
      • 5.2.2.4.1 Eszopiclone
      • 5.2.2.4.2 Zolpidem
      • 5.2.2.4.3 Zaleplon
      • 5.2.2.5 Other prescription sleep aids
      • 5.2.2.5.1 Tricyclic Antidepressants.
      • 5.2.2.5.2 Antipsychotics
      • 5.2.2.5.3 Chloral Derivatives
  • 5.3 Non-pharmacological Therapy
    • 5.3.1 Medical Devices
    • 5.3.2 Cognitive Behavioral Therapy
    • 5.3.3 Hypnotherapy
    • 5.3.4 Paradoxical intention
    • 5.3.5 Sleep hygiene education
    • 5.3.6 Stimulus control
    • 5.3.7 Other Alternative Therapies
      • 5.3.7.1 Acupuncture
      • 5.3.7.2 Bright light therapy
      • 5.3.7.3 Aroma therapy
      • 5.3.7.4 Music therapy
      • 5.3.7.5 Exercise/Yoga
      • 5.3.7.6 Biofeedback

6 Global Insomnia Market, By Disorder Duration

  • 6.1 Introduction
  • 6.2 Chronic Insomnia
  • 6.3 Transient Insomnia
  • 6.4 Acute Insomnia

7 Global Insomnia Market, By Disorder Condition

  • 7.1 Introduction
  • 7.2 Sleep onset and/or Maintenance
  • 7.3 Poor Quality of Sleep
  • 7.4 Other Disorder Condition

8 Global Insomnia Market, By Formulation Type

  • 8.1 Introduction
  • 8.2 Capsules
  • 8.3 Tablets
    • 8.3.1 Sublingual Tablets
    • 8.3.2 Film-Coated Tablets
  • 8.4 Oral mists

9 Global Insomnia Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Astellas
  • 11.2 Biocodex S A
  • 11.3 Consumer Healthcare Inc.
  • 11.4 Dainippon Sumitomo
  • 11.5 ECR Pharmaceuticals
  • 11.6 Eisai Co.
  • 11.7 Flynn Pharma
  • 11.8 Johnson & Johnson
  • 11.9 Meda Consumer Healthcare Inc.
  • 11.10 Merck & Co. Inc.
  • 11.11 Neurim
  • 11.12 Pernix Therapeutics
  • 11.13 Pfizer Inc
  • 11.14 Purdue Pharma L.P.
  • 11.15 Sanofi Pasteur
  • 11.16 SkyePharma
  • 11.17 Takeda Pharmaceutical Company

List of Tables

  • Table 1 Global Insomnia Market Outlook, By Region (2014-2023) ($MN)
  • Table 2 Global Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
  • Table 3 Global Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
  • Table 4 Global Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
  • Table 5 Global Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
  • Table 6 Global Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
  • Table 7 Global Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
  • Table 8 Global Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
  • Table 9 Global Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
  • Table 10 Global Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
  • Table 11 Global Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
  • Table 12 Global Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
  • Table 13 Global Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
  • Table 14 Global Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
  • Table 15 Global Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
  • Table 16 Global Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
  • Table 17 Global Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
  • Table 18 Global Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
  • Table 19 Global Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
  • Table 20 Global Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
  • Table 21 Global Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
  • Table 22 Global Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
  • Table 23 Global Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
  • Table 24 Global Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
  • Table 25 Global Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
  • Table 26 Global Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
  • Table 27 Global Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
  • Table 28 North America Insomnia Market Outlook, By Country (2014-2023) ($MN)
  • Table 29 North America Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
  • Table 30 North America Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
  • Table 31 North America Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
  • Table 32 North America Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
  • Table 33 North America Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
  • Table 34 North America Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
  • Table 35 North America Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
  • Table 36 North America Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
  • Table 37 North America Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
  • Table 38 North America Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
  • Table 39 North America Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
  • Table 40 North America Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
  • Table 41 North America Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
  • Table 42 North America Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
  • Table 43 North America Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
  • Table 44 North America Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
  • Table 45 North America Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
  • Table 46 North America Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
  • Table 47 North America Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
  • Table 48 North America Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
  • Table 49 North America Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
  • Table 50 North America Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
  • Table 51 North America Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
  • Table 52 North America Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
  • Table 53 North America Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
  • Table 54 North America Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
  • Table 55 Europe Insomnia Market Outlook, By Country (2014-2023) ($MN)
  • Table 56 Europe Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
  • Table 57 Europe Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
  • Table 58 Europe Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
  • Table 59 Europe Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
  • Table 60 Europe Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
  • Table 61 Europe Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
  • Table 62 Europe Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
  • Table 63 Europe Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
  • Table 64 Europe Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
  • Table 65 Europe Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
  • Table 66 Europe Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
  • Table 67 Europe Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
  • Table 68 Europe Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
  • Table 69 Europe Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
  • Table 70 Europe Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
  • Table 71 Europe Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
  • Table 72 Europe Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
  • Table 73 Europe Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
  • Table 74 Europe Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
  • Table 75 Europe Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
  • Table 76 Europe Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
  • Table 77 Europe Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
  • Table 78 Europe Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
  • Table 79 Europe Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
  • Table 80 Europe Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
  • Table 81 Europe Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
  • Table 82 Asia pacific Insomnia Market Outlook, By Country (2014-2023) ($MN)
  • Table 83 Asia pacific Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
  • Table 84 Asia pacific Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
  • Table 85 Asia pacific Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
  • Table 86 Asia pacific Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
  • Table 87 Asia pacific Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
  • Table 88 Asia pacific Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
  • Table 89 Asia pacific Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
  • Table 90 Asia pacific Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
  • Table 91 Asia pacific Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
  • Table 92 Asia pacific Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
  • Table 93 Asia pacific Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
  • Table 94 Asia pacific Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
  • Table 95 Asia pacific Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
  • Table 96 Asia pacific Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
  • Table 97 Asia pacific Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
  • Table 98 Asia pacific Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
  • Table 99 Asia pacific Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
  • Table 100 Asia pacific Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
  • Table 101 Asia pacific Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
  • Table 102 Asia pacific Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
  • Table 103 Asia pacific Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
  • Table 104 Asia pacific Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
  • Table 105 Asia pacific Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
  • Table 106 Asia pacific Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
  • Table 107 Asia pacific Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
  • Table 108 Asia pacific Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
  • Table 109 South America Insomnia Market Outlook, By Country (2014-2023) ($MN)
  • Table 110 South America Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
  • Table 111 South America Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
  • Table 112 South America Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
  • Table 113 South America Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
  • Table 114 South America Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
  • Table 115 South America Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
  • Table 116 South America Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
  • Table 117 South America Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
  • Table 118 South America Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
  • Table 119 South America Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
  • Table 120 South America Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
  • Table 121 South America Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
  • Table 122 South America Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
  • Table 123 South America Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
  • Table 124 South America Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
  • Table 125 South America Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
  • Table 126 South America Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
  • Table 127 South America Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
  • Table 128 South America Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
  • Table 129 South America Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
  • Table 130 South America Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
  • Table 131 South America Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
  • Table 132 South America Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
  • Table 133 South America Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
  • Table 134 South America Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
  • Table 135 South America Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
  • Table 136 Middle East & Africa Insomnia Market Outlook, By Country (2014-2023) ($MN)
  • Table 137 Middle East & Africa Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
  • Table 138 Middle East & Africa Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
  • Table 139 Middle East & Africa Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
  • Table 140 Middle East & Africa Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
  • Table 141 Middle East & Africa Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
  • Table 142 Middle East & Africa Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
  • Table 143 Middle East & Africa Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
  • Table 144 Middle East & Africa Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
  • Table 145 Middle East & Africa Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
  • Table 146 Middle East & Africa Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
  • Table 147 Middle East & Africa Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
  • Table 148 Middle East & Africa Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
  • Table 149 Middle East & Africa Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
  • Table 150 Middle East & Africa Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
  • Table 151 Middle East & Africa Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
  • Table 152 Middle East & Africa Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
  • Table 153 Middle East & Africa Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
  • Table 154 Middle East & Africa Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
  • Table 155 Middle East & Africa Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
  • Table 156 Middle East & Africa Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
  • Table 157 Middle East & Africa Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
  • Table 158 Middle East & Africa Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
  • Table 159 Middle East & Africa Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
  • Table 160 Middle East & Africa Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
  • Table 161 Middle East & Africa Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
  • Table 162 Middle East & Africa Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
Back to Top